Literature DB >> 18844594

Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice.

Jean-François Nicolas1, Bruno Guy.   

Abstract

The dermis and epidermis are alternative sites for prophylactic vaccination that have received renewed interest in recent years, not only because of the ease of access to the skin, but also its unique immunological properties. This review discusses the characteristics of the skin, current knowledge on skin immunity and clinical experience with cutaneous immunization against infectious diseases, with a special focus on intradermal immunization. The most widely accepted paradigm explaining the efficacy of cutaneous immunization is reviewed and recent research suggesting where this paradigm may need some refinement is highlighted. Clinical investigations that have concentrated on the intradermal route to vaccinate against influenza, rabies or hepatitis B support the current knowledge on skin immunity and, when combined with recent progress made in the development of user-friendly injection systems, have stimulated the ongoing clinical development of novel vaccines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18844594     DOI: 10.1586/14760584.7.8.1201

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  79 in total

Review 1.  Inactivated influenza vaccines: recent progress and implications for the elderly.

Authors:  Valentina Parodi; Daniela de Florentiis; Mariano Martini; Filippo Ansaldi
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

Review 2.  [Immunosenescence and vaccinations in the elderly].

Authors:  Hans Joachim Hutt; Petra Bennerscheidt; Britta Thiel; Manuela Arand
Journal:  Med Klin (Munich)       Date:  2010-12-07

3.  Induction of mucosal immunity through systemic immunization: Phantom or reality?

Authors:  Fei Su; Girishchandra B Patel; Songhua Hu; Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

4.  A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients.

Authors:  Doris Lambracht-Washington; Roger N Rosenberg
Journal:  Neurobiol Aging       Date:  2014-12-12       Impact factor: 4.673

Review 5.  An update on the use of laser technology in skin vaccination.

Authors:  Xinyuan Chen; Ji Wang; Dilip Shah; Mei X Wu
Journal:  Expert Rev Vaccines       Date:  2013-10-16       Impact factor: 5.217

6.  Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice.

Authors:  Roger N Rosenberg; Min Fu; Doris Lambracht-Washington
Journal:  J Neuroimmunol       Date:  2018-06-11       Impact factor: 3.478

Review 7.  Vaccines: the fourth century.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2009-09-30

8.  Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.

Authors:  H S Gill; J Söderholm; M R Prausnitz; M Sällberg
Journal:  Gene Ther       Date:  2010-03-04       Impact factor: 5.250

9.  Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats.

Authors:  Koen van der Maaden; Sebastiaan J Trietsch; Heleen Kraan; Eleni Maria Varypataki; Stefan Romeijn; Raphäel Zwier; Heiko J van der Linden; Gideon Kersten; Thomas Hankemeier; Wim Jiskoot; Joke Bouwstra
Journal:  Pharm Res       Date:  2014-01-28       Impact factor: 4.200

10.  Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI) questionnaire.

Authors:  Catherine Chevat; Muriel Viala-Danten; Carla Dias-Barbosa; Van Hung Nguyen
Journal:  Health Qual Life Outcomes       Date:  2009-03-04       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.